Opera Trading Capital’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-55,000
Closed -$1.66M 142
2016
Q2
$1.66M Buy
+55,000
New +$1.12M 0.36% 57

Opera Trading Capital's CPXX Position: Q3 2016 in Review

Opera Trading Capital sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 55,000 shares — an estimated $1.66M sold.

Opera Trading Capital first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $1.66M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Opera Trading Capital reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Opera Trading Capital sold 55,000 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $1.66M.
  • Opera Trading Capital first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Opera Trading Capital's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $1.66M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Opera Trading Capital's 13F filing for Q3 2016, filed 14 Nov 2016.